Medicare's GLP-1 discount program, aimed at helping obese patients afford weight loss medications, excludes those with certain medical conditions like sleep apnea, despite these individuals often having the highest need for such drugs. This exclusion leaves many patients unable to access affordable treatment, highlighting a significant gap in healthcare coverage that disproportionately affects those with complex health issues.
Read the full article at KFF Health News
Want to create content about this topic? Use Nemati AI tools to generate articles, social posts, and more.



